PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
PRVL
Delisted
PRVL was delisted on the 21st of January, 2021.
93 hedge funds and large institutions have $648M invested in Prevail Therapeutics Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 16 increasing their positions, 27 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
77% less call options, than puts
Call options by funds: $3.68M | Put options by funds: $15.8M
Holders
93
Holding in Top 10
2
Calls
$3.68M
Puts
$15.8M
Top Buyers
| 1 | +$19.8M | |
| 2 | +$16.4M | |
| 3 | +$13.7M | |
| 4 |
Millennium Management
New York
|
+$12.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.4M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$17.9M | |
| 3 | -$14.3M | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$11.5M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$10.9M |
